COVID Westward Migration Continues
Key Points: In today’s Recommendation for Industry, we take a look at the latest statistics on COVID and expectations for the next few months. Read
Key Points: In today’s Recommendation for Industry, we take a look at the latest statistics on COVID and expectations for the next few months. Read
Key Points: In today’s Recommendation for Industry, we provide updates on COVID-19 and Monkeypox. Read more below. Pfizer’s Omicron-Targeting COVID-19 Vaccines Generate Stronger Immune Response.
In 2021, more than half of the importers whose Foreign Supplier Verification Programs (FSVPs) were assessed by FDA received 483s for a non-compliance. FDA also
Is that CFIA inspector at your food facility door really a CFIA inspector? In a May Tweet, the Canadian Food Inspection Agency (CFIA) stated that
Key Points: In today’s Recommendation for Industry, we discuss the encouraging trajectory of COVID based on TAG’s matrix and CDC’s mapping. Read more below. Women
Key Points: In today’s Recommendation for Industry, we discuss the low risk of monkeypox in the US, and what businesses can do to keep it
The recent shortages of infant formula and the fallout from prior facility inspections of the manufacturer have most certainly energized Congress to take action that
FDA has been very clear that CBD is not approved for any uses in food or as a dietary supplement, and it has approved only
Key Points: In today’s Recommendation for Industry, we discuss the current data on COVID case rates and hospitalizations. Read more below. FDA committee approves Moderna
Key Points: In today’s Recommendation for Industry, we discuss the recent monkeypox outbreak. Read more below. In-utero COVID exposure tied to language, motor delays by